Raras
Buscar doenças, sintomas, genes...
Fechamento prematuro do canal arterial
ORPHA:95486CID-10 · Q25.8CID-11 · LA8B.YDOENÇA RARA

A história do beisebol nos Estados Unidos remonta ao século XIX, quando rapazes e entusiastas amadores jogavam um jogo semelhante ao beisebol com regras informais próprias, utilizando equipamentos caseiros. A popularidade do esporte aumentou e, entre as décadas de 1830 e 1850, foram formados clubes amadores masculinos. Na década de 1860, surgiram clubes de beisebol semi-profissionais, e as primeiras ligas profissionais apareceram na década de 1870, após a Guerra de Secessão.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

O fechamento prematuro do canal arterial é uma condição rara onde o ducto arterioso se fecha antes do nascimento, impedindo o fluxo sanguíneo normal para os pulmões. Isso pode levar a insuficiência cardíaca e hipertensão pulmonar no recém-nascido.

🏥
SUS: Cobertura mínimaScore: 20%
Triagem neonatal (Fase 5)CID-10: Q25.8
🇧🇷Dados SUS / DATASUS
PROCEDIMENTOS SIGTAP (5)
0202010503
Cariótipo — bandas G, Q ou Rgenetic_test
0202010600
Pesquisa de microdeleções/microduplicações por FISHlab_test
0202010694
Sequenciamento completo do exoma (WES)rehabilitation
0202010260
Dosagem de alfa-fetoproteína
0301070040
Atendimento em reabilitação — doenças raras
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa4
Últimos 10 anos200publicações
Pico202570 papers
Linha do tempo
2022Hoje · 2026🧪 2004Primeiro ensaio clínico📈 2025Ano de pico
Publicações por ano (últimos 10 anos)

Triagem neonatal (Teste do Pezinho)

👶
Teste: qPCR para deleção de SMN1 em sangue seco
Fase 5 do PNTNpending
Incidência no Brasil: 1:10.000

A triagem neonatal permite diagnóstico precoce e início imediato do tratamento.

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

🧬

Nenhum gene associado encontrado

Os dados genéticos desta condição ainda estão sendo catalogados.

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
2Fase 21
·Pré-clínico4
Medicamentos catalogadosEnsaios clínicos· 0 medicamentos · 5 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Fechamento prematuro do canal arterial

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

🟢 Recrutando agora

1 pesquisa recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

Outros ensaios clínicos

0 ensaios clínicos encontrados.

Distribuição por fase
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
0 papers (10 anos)
#1

Enteral feeding during cyclooxygenase inhibitor treatment for patent ductus arteriosus: A systematic review.

Pediatrics international : official journal of the Japan Pediatric Society2026

This study evaluated the effect of modifying enteral feeding during cyclooxygenase inhibitor (COXI) treatment on patent ductus arteriosus (PDA) in preterm infants. We searched MEDLINE, EMBASE, CENTRAL, CINAHL, and ICHUUSHI databases for randomized and nonrandomized controlled trials, checked the references lists and major clinical trials. Non-human and non-English studies were excluded. Evidence was assessed using the Grading of Recommendations, Assessment, Development, and Evaluation. Preterm infants born before 37 weeks of gestation are treated with COXIs for PDA, including indomethacin and ibuprofen. The primary outcomes were the composite outcome of necrotizing enterocolitis (NEC) or gastrointestinal perforation and its components (NEC and gastrointestinal perforation). Two randomized controlled trials (n = 303) and one retrospective cohort study (n = 261) were included (total: n = 564). No significant differences were observed in the composite gastrointestinal outcome (risk ratio [RR]: 1.10, 95% confidence interval [CI]: 0.51-2.37; 1 study, 177 infants, very low certainty of evidence [CoE]), NEC (RR: 1.01, 95% CI: 0.47-2.15; 2 studies, 300 infants, very low CoE), or gastrointestinal perforation (RR: 1.94, 95% CI: 0.25-14.81; 2 studies, 300 infants, very low CoE) between discontinuation and continuation of enteral feeding. Discontinuation of enteral feeding resulted in a significantly lower rate of surgical closure for PDA compared to continuation (RR: 0.56, 95% CI: 0.37-0.86; 1 study, 177 infants, low CoE). Neither discontinuation nor continuation of enteral feeding significantly affected the composite gastrointestinal outcome and its components (NEC and gastrointestinal perforation).

#2

Patent ductus arteriosus: emerging trial evidence firmly supports conservative management in preterm infants.

Current opinion in pediatrics2026 Apr 01

To summarize recent evidence from randomized clinical trials (RCT) and meta-analysis of patent ductus arteriosus (PDA) closure therapies versus conservative/expectant management on key outcomes such as bronchopulmonary dysplasia (BPD) or death in very preterm (<32 weeks' gestation) infants. Of 10 completed RCTs in the past decade of medical therapies before 2 weeks of age to close a PDA, none demonstrated benefit in reducing moderate-severe BPD/death by 36 weeks postmenstrual age as compared to placebo treatment. When combined, the meta-analysis of the 10 RCTs showed an elevated risk of BPD/death [relative risk (RR): 1.10, 95% confidence interval (CI), 1.01-1.19) and higher risk of death by 36 weeks postmenstrual age or discharge (RR: 1.25; 95% CI, 1.01-1.56). A 2025 Cochrane meta-analysis also found a similar concerning trend of increased mortality following early medical treatment for PDA. Despite their recent popularity, there are no published trials demonstrating safety or efficacy of transcatheter PDA closure. We now have ample evidence for all clinicians to finally acknowledge that conservative PDA management is the correct path forward. Clinical experimentation is no longer acceptable, and expectant PDA management must be adopted as the current standard if we are to adhere to our foundational principle, 'first, do no harm'.

#3

Premature foramen ovale restriction/closure in pregnancy: echocardiographic features and overlap with aortic coarctation.

The journal of maternal-fetal &amp; neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians2026 Dec

Evaluation of the foramen ovale (FO) is essential for understanding right heart predominance in the fetal circulation during the third trimester. Rather than considering the FO as a simple orifice, it should be assessed as a complex anatomical and functional system. Premature FO restriction or closure represents a clinically relevant but diagnostically challenging condition in fetal echocardiography. We conducted a monocentric retrospective study including 600 uncomplicated pregnancies between 22 and 38 weeks of gestation that underwent fetal echocardiography at the Cardiology Service of ASP Reggio Calabria between January and December 2023. The FO was assessed by evaluating septum primum morphology and mobility, ostium secundum configuration, and interatrial shunt direction and magnitude on color Doppler, together with indirect hemodynamic markers. All examinations were conducted by a single operator. All pregnancies resulted in term deliveries with normal neonatal outcomes, and postnatal follow-up lasted 6-9 months. Restrictive or premature closure of the FO was identified in 9 fetuses (incidence 1:66 pregnancies), with FO restrictiveness observed in seven cases and premature closure in two cases. Reduced interatrial shunting was defined as a limited or absent right-to-left flow across the FO on color Doppler, associated with impaired septum primum mobility and/or altered FO geometry. The most consistent indirect echocardiographic sign was right atrial dilation (100% of cases), followed by right ventricular and pulmonary artery predominance with a widely patent ductus arteriosus. In some fetuses, the FO appeared morphologically wide but functionally restrictive. All cases showed favorable early postnatal outcomes. This study evaluates the incidence of FO restriction or premature closure in physiologically normal pregnancies during the third trimester and reviews echocardiographic features useful for its identification.

#4

Fetal Intervention for Giant Chorangioma with Prenatal Ductus Arteriosus Closure: A Case Report.

Fetal diagnosis and therapy2026 Mar 05

Introduction We present a case of spontaneous premature ductus arteriosus (DA) closure following modified interstitial laser ablation (ILA) of a giant chorangioma (GC) in a fetus with evidence of hydrops. Case presentation A 26-week ultrasound revealed a 10-cm GC in the posteriorly located placenta with signs of fetal hydrops, polyhydramnios, and elevated middle cerebral artery peak systolic velocity (MCA PSV) of 1.9 MoM. Preoperative fetal echocardiogram showed elevated combined cardiac output (753 ml/kg/min) without structural abnormalities. Modified ILA targeting the branches of the feeder artery with an extended-pulse technique (30 seconds at 40 Watts) followed by intrauterine fetal transfusion were performed without complications. On post-operative day (POD) 1, new onset of ductus venosus flow reversal was noted, which was attributed to post-procedural hemodynamics. Fetal echocardiography on POD 5 suggested constriction of DA; follow-up confirmed complete DA closure and secondary right heart dysfunction. The pregnancy was managed expectantly with at least weekly echocardiograms. Digoxin and hyperoxygenation for fetal heart failure did not change DA caliber. Acetaminophen and fluoxetine were discontinued without improvement. After an uncomplicated term cesarean delivery (indication: breech), the female neonate was discharged home on day of life 3. Currently, the child is 6 months old and healthy. Conclusion Modified ILA for GC followed by expectant management of associated DA closure yielded a term delivery with a favorable outcome.

#5

Favorable Procedural Outcomes in Lower Versus Higher Weight Premature Infants Undergoing Transcatheter Patent Ductus Arteriosus Closure.

Journal of the Society for Cardiovascular Angiography &amp; Interventions2026 Feb

Timing of device closure of patent ductus arteriosus (PDA) in preterm infants has been a topic of debate. Limited data exist comparing procedural outcomes based on infant weight at the time of the procedure. This study aimed to compare procedural outcomes and adverse events between premature infants weighing <2 kg and those weighing 2 to 5 kg undergoing PDA device closure. We performed a retrospective review of premature infants (<37 weeks gestational age) who underwent transcatheter PDA closure at 2 institutions between 2013 and 2022. Patients were divided into 2 groups: group 1 (<2 kg) and group 2 (2-5 kg). Demographic characteristics, procedural characteristics, success rates, and adverse events were analyzed. Procedural success was defined as successful device placement with no more than small residual shunt and no device embolization within 24 hours. A total of 177 patients were included: 81 in group 1 (<2 kg) and 96 in group 2 (2-5 kg). Procedure success was significantly higher in group 1 than in group 2 (94% vs 83%, P = .031). Group 1 also had shorter median procedure time (50 vs 67 minutes, P = .002) and fluoroscopy time (6.4 vs 11.4 minutes, P < .0001). Adverse events occurred in 11.9% of patients, with a lower rate in group 1, but was not statistically significant (8.6% vs 14.6%, P = .22). No procedure-related mortality occurred. Procedural outcomes of transcatheter PDA closure in premature infants are more favorable among smaller infants with higher success rates and fewer adverse events. Lower weight alone should not delay transcatheter PDA closure in preterm infants with hemodynamically significant PDA.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC2 artigos no totalmostrando 200

2026

Premature foramen ovale restriction/closure in pregnancy: echocardiographic features and overlap with aortic coarctation.

The journal of maternal-fetal &amp; neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians
2026

Fetal Intervention for Giant Chorangioma with Prenatal Ductus Arteriosus Closure: A Case Report.

Fetal diagnosis and therapy
2026

Favorable Procedural Outcomes in Lower Versus Higher Weight Premature Infants Undergoing Transcatheter Patent Ductus Arteriosus Closure.

Journal of the Society for Cardiovascular Angiography &amp; Interventions
2026

Transient isolated right ventricular hypertrophy: A benign phenotype in neonates: Case series and review of the literature.

Scottish medical journal
2026

An Unusual Case of Acquired Dilated Cardiomyopathy Due to Long-Standing Patent Ductus Arteriosus.

Cureus
2026

Enteral feeding during cyclooxygenase inhibitor treatment for patent ductus arteriosus: A systematic review.

Pediatrics international : official journal of the Japan Pediatric Society
2026

Outcome after Selective early treatment for Closure of patent ductus ARteriosus in preterm babies, a multicentre, masked, randomised placebo-controlled parallel group trial (Baby-OSCAR trial).

Health technology assessment (Winchester, England)
2026

Prolonged patent ductus arteriosus exposure and risk for late acute kidney injury in extremely preterm infants.

Journal of perinatology : official journal of the California Perinatal Association
2026

Late Aortic Obstruction Post Patent Ductus Arteriosus Closure Managed with Renata Minima Stent.

Pediatric cardiology
2025

Risk factors for hemodynamically significant patent ductus arteriosus and ibuprofen treatment failure in premature twins: a retrospective case-control study.

Frontiers in cardiovascular medicine
2026

Patent ductus arteriosus: emerging trial evidence firmly supports conservative management in preterm infants.

Current opinion in pediatrics
2025

Paracetamol or ibuprofen? A pilot study comparing rescue therapy for PDA in preterm infants within the first month.

Frontiers in pediatrics
2025

Patterns of Segmental Strain of the Left Ventricle in Extremely Premature Infants.

Pediatric reports
2025

Association between hemodynamically significant patent ductus arteriosus and fluid intake in the first week of life in a cohort of very low birth weight preterm infants: the COOL study.

European journal of pediatrics
2025

Expanding the literature on Cantú syndrome: recognising early clinical and phenotypic clues.

BMJ case reports
2025

[Efficacy and safety of ibuprofen for the treatment of patent ductus arteriosus in preterm infants of different postnatal ages].

Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics
2026

A B-Type Natriuretic Peptide-Based Machine Learning Model for Early Hemodynamic Symptomatic Patent Ductus Arteriosus Prediction.

Neonatology
2025

Pulmonary artery sling with complete tracheal rings in an extremely low-weight premature infant: a case report.

Cardiology in the young
2025

In-hospital and neurodevelopmental outcomes of treatment strategies for patent ductus arteriosus in preterm infants: A retrospective cohort study.

Pediatrics and neonatology
2025

Transcatheter Closure of the Ductus Arteriosus in a Premature Neonate: A Team Effort.

Clinics in perinatology
2025

The efficiency and safety of low-dose intravenous indomethacin for closure of patent ductus arteriosus in preterm neonate: a randomized controlled trial.

Scientific reports
2025

Prolonged Pregnancy Following Long-Term Celecoxib Use in a Case of Uterine Adenomyosis: A Case Report.

The journal of obstetrics and gynaecology research
2025

Machine learning-based tool to assess risk of hemodynamically significant PDA in extremely premature infants.

Pediatric research
2025

Does Phototherapy Affect Ductus Arteriosus Closure in Preterm Infants ≤32 Weeks of Gestation, and Can We Influence This Through Chest Shielding? Review of the Literature and a Meta-Analysis.

Biomedicines
2025

Two case reports of idiopathic prenatal closure of the ductus arteriosus complicated at birth by severe pulmonary hypertension successfully treated without intubation.

Translational pediatrics
2026

Impact of the Time to Initiation of Indomethacin or Ibuprofen on Patent Ductus Arteriosus Closure Rates.

Paediatric drugs
2025

Venous-Only Approach for Transcatheter Patent Ductus Arteriosus Closure in Infants: Is It Time for Change?

Journal of the Society for Cardiovascular Angiography &amp; Interventions
2026

Comparison of neurodevelopmental outcomes of extremely preterm infants undergoing trans-catheter closure of the patent ductus arteriosus compared to surgical ligation.

Journal of perinatology : official journal of the California Perinatal Association
2025

Case Report: Simultaneous covered stenting for aortic coarctation and significant PDA in low and very low birth weight preterm infants: technical insights from two cases.

Frontiers in cardiovascular medicine
2025

A Discourse on Percutaneous Closure of the Patent Ductus Arteriosus in Premature Neonates: Controversy, Remedy, or Paradox of Choice?

CJC pediatric and congenital heart disease
2025

Paracetamol Concentrations and Time-Course of Ductus Arteriosus Diameter in Extremely Preterm Neonates: A Population Pharmacokinetic-Pharmacodynamic Analysis.

Clinical pharmacokinetics
2025

Evaluating the efficacy and safety of milrinone for prevention of post-patent ductus arteriosus closure syndrome (the MIDAS trial) in extremely preterm infants: a multicentre, double-masked, randomised, placebo-controlled trial.

BMJ open
2025

Ductus Arteriosus Variability Linked to Maternal Drug Exposure: Assessment of the USFDA Adverse Event Reporting System using Disproportionality Analysis.

Current vascular pharmacology
2025

Feasibility and Safety of Percutaneous Device Closure of Patent Ductus Arteriosus in Preterm Neonates: Experience From a Single Center in Northern India.

Indian pediatrics
2025

Impact of Pulmonary Hypertension and Patent Ductus Arteriosus in Preterm Infants with Presumed Pulmonary Hypoplasia.

Biomedicines
2025

Pharmacologic Management of Patent Ductus Arteriosus in the Neonatal Intensive Care Unit: A Retrospective Study.

The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG
2025

The First Percutaneous Closures of Patent Ductus Arteriosus in Premature Neonates in Serbia: A Case Report Series.

Reports (MDPI)
2025

Patent Ductus Arteriosus in Extremely Preterm Infants: Update on Current Diagnostic and Treatment Options.

Current treatment options in cardiovascular medicine
2025

Outcomes of extremely preterm infants with bronchopulmonary dysplasia: a retrospective cohort study.

Scientific reports
2025

Does early-targeted risk-based management of a patent ductus arteriosus improve outcomes in preterm infants? Insights from an observational study.

BMJ paediatrics open
2025

A rare vascular complication in a preterm neonate: iliac artery injury following patent ductus arteriosus device closure.

Cardiology in the young
2025

Association Between Patent Ductus Arteriosus and the Development of Treatment-Requiring Retinopathy of Prematurity in Preterm Infants: A Single-Center Cohort Study.

Children (Basel, Switzerland)
2025

Piccolo Device for Treating Patent Ductus Arteriosus Beyond Premature Newborn Patients, a Novel Experience in South America: A Retrospective Study.

Health science reports
2025

Early treatment versus expectant management of hemodynamically significant patent ductus arteriosus for preterm infants.

The Cochrane database of systematic reviews
2025

MicroRNA Expression Profiles in Very Preterm Infants with Patent Ductus Arteriosus: A Pilot Study.

Neonatology
2026

Effect of Transcatheter Closure of the Ductus Arteriosus on Right Ventricular Function in Preterm Neonates.

Pediatric cardiology
2026

In-hospital outcomes of early versus late transcatheter closure of patent ductus arteriosus in preterm infants.

Journal of neonatal-perinatal medicine
2025

Updates in interventional cardiology in children with cardiac disease.

European journal of pediatrics
2025

Current approaches to the patent ductus arteriosus: Implications for pulmonary morbidities.

Paediatric respiratory reviews
2025

Respiratory Outcomes After Transcatheter vs Surgical Patent Ductus Arteriosus Closure in Preterm Infants.

JAMA network open
2025

Anthropometric measurements of infants in a risk-based patent ductus arteriosus treatment program.

Early human development
2025

Association between negative T waves in lead V1 and delayed patent ductus arteriosus closure in preterm neonates.

Journal of cardiothoracic surgery
2025

Venous Access Alone Versus Arterial and Venous Access for Patent Arterial Duct Device Closure in Childhood.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography &amp; Interventions
2025

Mean Platelet Volume to Platelet Distribution Width Ratio: The Most Effective Platelet Parameter in the Closer of Ductus Arteriosus.

Arquivos brasileiros de cardiologia
2025

Improvement of pulmonary edema and respiratory status after transcatheter PDA closure in the smallest and most premature infants.

Frontiers in pediatrics
2025

Combination therapy for patent ductus arteriosus in preterm infants: Narrative review.

Journal of neonatal-perinatal medicine
2024

Persistent pulmonary hypertension of the newborn infant (PPHN) due to premature closure of the ductus arteriosus (DA).

Case reports in perinatal medicine
2025

Patent Ductus Arteriosus in Preterm Infants.

Pediatrics
2025

Changes During Reopening in Premature Constriction or Closure of the Ductus Arteriosus: A Report of Two Cases.

Cureus
2026

The Timing and Factor of Ductus Arteriosus Closure in Infants with Down Syndrome Born at Term and Late-Preterm.

Pediatric cardiology
2025

Heterogeneity in treatment response for patent ductus arteriosus: a meta-analysis.

European journal of pediatrics
2025

A Retrospective Analysis of PK and Response of Oral Ibuprofen in the Treatment of a Patent Ductus Arteriosus in Extremely Low Gestational Age Neonates.

Journal of clinical pharmacology
2025

Assessment of the relationship between serum magnesium levels, patent ductus arteriosus, and other neonatal morbidities: a retrospective observational study.

Cardiology in the young
2025

Development and Validation of a Novel Deep Learning Model to Predict Pharmacologic Closure of Patent Ductus Arteriosus in Premature Infants.

Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography
2026

Impact of PDA Closure Methodology on Peri-procedural Opioid Utilization in Preterm Neonates, a Cross-Sectional Review in a Tertiary Pediatric Healthcare System.

Pediatric cardiology
2024

Toward "S"-Shaped 3D-Printed Soft Robotic Guidewires for Pediatric Patent Ductus Arteriosus Endovascular Interventions.

IEEE International Conference on Soft Robotics. IEEE International Conference on Soft Robotics
2025

The Course of Ductus Arteriosus from the Neonatal Period to Childhood in a Moderate Altitude Region.

High altitude medicine &amp; biology
2025

The Effect on Extubation of Early vs. Late Definitive Closure of the Patent Ductus Arteriosus in Premature Infants: A Target Trial Emulation Using Electronic Health Records.

Journal of clinical medicine
2026

Largest Single-Center Experience Using the Micro Vascular Plug (MVP) for Transcatheter Closure of Premature Patent Ductus Arteriosus.

Pediatric cardiology
2025

Patent ductus arteriosus rupture during percutaneous device closure: a case report.

Cardiology in the young
2025

Patent Ductus Arteriosus, Hydrocortisone, and Outcome among Infants Born Extremely Preterm: Secondary Analysis of the Hydrocortisone Trial.

The Journal of pediatrics
2025

Management of the patent ductus arteriosus among infants born at 23 to 32 weeks' gestation between 2011 to 2022: a report from in the Children's Hospitals Neonatal Consortium.

Journal of perinatology : official journal of the California Perinatal Association
2026

Echocardiographic Predictors and Incidence of Left Ventricular Dysfunction Following Transcatheter Patent Ductus Arteriosus Closure in Extremely Premature Infants.

Pediatric cardiology
2025

High-Humidity Care May Prevent the Development of Patent Ductus Arteriosus in Premature Infants.

Circulation journal : official journal of the Japanese Circulation Society
2025

Clinical and echocardiographic predictors of medical therapy failure for patent ductus arteriosus closure in preterm infants: Insights from a risk-based treatment approach.

Early human development
2024

Oral ibuprofen versus placebo in closure of patent ductus arteriosus in preterm neonates, a randomized control trial.

Journal of neonatal-perinatal medicine
2024

Association of cytochrome P450 CYP2C9 (rs1057910) gene polymorphism and ibuprofen response in preterm neonates diagnosed with patent ductus arteriosus.

Journal of neonatal-perinatal medicine
2025

TREOCAPA: prophylactic treatment of the ductus arteriosus in preterm infants by acetaminophen-statistical analysis plan for the randomized phase III group sequential trial.

Trials
2025

Risk Factors Associated With the Development of Late Pulmonary Artery Hypertension in Extremely Premature Infants.

Pediatric pulmonology
2024

Low-profile KA microplug set for transarterial occlusion of patent ductus arteriosus in a small dog: First experience in interventional cardiology.

Open veterinary journal
2025

Safety and Efficacy of Zero Fluoroscopy Patent Ductus Arteriosus Closure in Comparison to the Standardized Fluoroscopy-Guided Procedure: A Systematic Review and Meta-Analysis.

Current cardiology reviews
2025

Outcomes of Patent Ductus Arteriosus Closure by Availability of Cardiac Surgeons for Infants Born Preterm.

The Journal of pediatrics
2025

Patent ductus arteriosus closure in infants weighing less than 1500 g via a tiny microcatheter: a simple technique with zero-contrast exposure.

Cardiology in the young
2025

[Transcatheter closure of patent ductus arteriosus in an extremely low birth weight preterm infant].

Zhonghua er ke za zhi = Chinese journal of pediatrics
2026

Patent Ductus Arteriosus Morphology Changes in Preterm Neonates Undergoing Transcatheter Device Closure.

Pediatric cardiology
2024

[Prolonged treatment of patent ductus arteriosus with paracetamol in very low birth weight preterm infants].

Andes pediatrica : revista Chilena de pediatria
2024

Transcatheter Embolization in Congenital Cardiovascular Malformations-Variable Use of Vascular Plugs.

Cardiovascular therapeutics
2024

Fluid restriction for treatment of symptomatic patent ductus arteriosus in preterm infants.

The Cochrane database of systematic reviews
2025

The effect of anti-scatter grids on radiation exposure during transcatheter patent ductus arteriosus closure in premature infants.

Cardiology in the young
2024

Therapeutic Efficacy and Safety of Paracetamol versus Ibuprofen in Patent Ductus Arteriosus in Newborns: A Systematic Review.

Arquivos brasileiros de cardiologia
2024

Systemic Inflammatory Indices as New Biomarkers for Hemodynamically Significant Ductus Arteriosus.

Arquivos brasileiros de cardiologia
2025

Effectiveness of repeated pharmacological courses for patent ductus arteriosus in preterm infants.

Early human development
2024

Late postnatal steroid treatment using oral betamethasone can help to close ductus arteriosus in extremely preterm infants who cannot be weaned from ventilation.

European journal of pediatrics
2025

Prophylactic low-dose hydrocortisone in neonates born extremely preterm: current knowledge and future challenges.

Pediatric research
2024

Population Pharmacokinetics of Intravenous Paracetamol and Its Metabolites in Extreme Preterm Neonates in the Context of Patent Ductus Arteriosus Treatment.

Clinical pharmacokinetics
2024

Staged biventricular repair in a premature neonate with critical aortic stenosis, severe mitral regurgitation, and fetal hydrops: a case report.

General thoracic and cardiovascular surgery cases
2025

Airway Management With Congenital Tracheal Stenosis: Surgical and Anesthetic Consideration.

The Laryngoscope
2024

Patent ductus arteriosus closure in small infants weighing less than 1500 g using KA micro plug: steps and tips.

Cardiology in the young
2024

Furosemide for patent ductus arteriosus during cyclooxygenase inhibitor therapy: A systematic review.

Pediatrics international : official journal of the Japan Pediatric Society
2024

The Potential of Ambroxol as a Panacea for Neonatal Diseases: A Scoping Review.

Cureus
2024

Device Closure of Hemodynamically Significant Patent Ductus Arteriosus in Premature Infants.

JACC. Advances
2025

Assessment of Blood Prostaglandin E2 Metabolite Levels among Infants Born Preterm with Patent Ductus Arteriosus: A Prospective Study.

The Journal of pediatrics
2024

Percutaneous versus surgical closure of patent ductus arteriosus in low-weight premature infants: 10-year experience in a tertiary center.

Anales de pediatria
2025

Impact of a Multidisciplinary Service Line and Program for Transcatheter Device Closure of the Neonatal Ductus Arteriosus.

Pediatric cardiology
2025

Perinatal Factors Associated with Successful Pharmacologic Closure of the Patent Ductus Arteriosus in Premature Infants.

Pediatric cardiology
2024

Blood pressure increase preceded spontaneous and paracetamol-induced, early ductal closure in very preterm infants.

Acta paediatrica (Oslo, Norway : 1992)
2025

Transcatheter Patent Ductus Arteriosus Closure in Premature Infants: Comparison of Echocardiogram and Angiogram Measurements.

Pediatric cardiology
2024

Left Pulmonary Artery Occlusion Following Device Closure of Patent Ductus Arteriosus in Premature Infants.

Journal of the Society for Cardiovascular Angiography &amp; Interventions
2024

Efficacy of paracetamol in the management of hemodynamically significant patent ductus arteriosus in preterm newborns.

Indian journal of pharmacology
2025

Premature Closure of the Ductus Arteriosus and Veno-Arterial Extracorporeal Membrane Oxygenation in Critically Ill Neonates: A 10-Year Single-Center Retrospective Study.

Pediatric cardiology
2024

Selective early medical treatment of the patent ductus arteriosus in extremely low gestational age infants: a pilot randomised controlled trial protocol (SMART-PDA).

BMJ open
2024

Acetaminophen for Patent Ductus Arteriosus and Risk of Mortality and Pulmonary Morbidity.

Pediatrics
2024

Transcatheter and Surgical Ductus Arteriosus Closure in Very Low Birth Weight Infants: 2018-2022.

Pediatrics
2024

Procedural closure of the patent ductus arteriosus in preterm infants: a clinical practice guideline.

Journal of perinatology : official journal of the California Perinatal Association
2024

At a crossroads for early medical treatment of persistent patent ductus arteriosus in preterm infants.

Journal of perinatology : official journal of the California Perinatal Association
2024

Enteral Feedings Do Not Increase the Risk of NEC in ELBW Infants Undergoing Treatment of Patent Ductus Arteriosus With Acetaminophen.

The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG
2024

Patent Ductus Arteriosus Occlusion in Premature Infants.

Interventional cardiology clinics
2024

Morbidity and neurodevelopmental outcomes at 2 years in preterm infants undergoing percutaneous transcatheter closure vs. surgical ligation of the PDA.

Journal of perinatology : official journal of the California Perinatal Association
2024

Use of Paracetamol for Treatment of Patent Ductus Arteriosus in Preterm Neonates: A 5-Year Experience From a Tertiary Hospital in India.

Indian pediatrics
2024

Who Still Gets Ligated? Reasons for Persistence of Surgical Ligation of the Patent Ductus Arteriosus Following Availability of Transcatheter Device Occlusion for Premature Neonates.

Journal of cardiovascular development and disease
2025

Assessing the State of Training in Congenital Interventional Cardiology: A Global Survey of Program Directors.

Pediatric cardiology
2024

Patent ductus arteriosus management in very-low-birth-weight prematurity: a place for an early operation?

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery
2024

The American Association for Thoracic Surgery (AATS) 2024 expert consensus document: Management of neonates and infants with Ebstein anomaly.

The Journal of thoracic and cardiovascular surgery
2024

Echocardiographic findings and pregnancy outcomes for fetuses with complete closure of the ductus arteriosus.

Journal of clinical ultrasound : JCU
2024

Safety and feasibility pilot study of continuous low-dose maternal supplemental oxygen in fetal single ventricle heart disease.

Ultrasound in obstetrics &amp; gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology
2024

A comparison of different dosing regimen of intravenous paracetamol for hemodynamically significant patent ductus arteriosus closure in premature neonates <32 weeks: a prospective observational study.

Journal of perinatology : official journal of the California Perinatal Association
2024

Cardiorespiratory Instability after Percutaneous Patent Ductus Arteriosus Closure: A Multicenter Cohort Study.

The Journal of pediatrics
2024

Transcatheter patent ductus arteriosus closure in premature infants requiring high-frequency ventilation.

Cardiology in the young
2024

Proactive Diagnosis and Tailor-Made Treatment of Patent Ductus Arteriosus in Very Preterm Infants with Routine Echocardiography in Japan: A post hoc Analysis of the PLASE Study.

Neonatology
2024

Mobile bedside ductus arteriosus closure in severely premature neonates using only echocardiographic guidance.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography &amp; Interventions
2024

Impact of catheterized ductal closure on renal and cerebral oximetry in premature neonates.

European journal of pediatrics
2024

Transcatheter Patent Ductus Arteriosus Closure in Premature Infants: A Multicenter Retrospective Study Comparing Available Devices.

Circulation. Cardiovascular interventions
2024

Active versus restrictive ligation strategy for patent ductus arteriosus - A retrospective two-center study of extremely preterm infants born between 22 + 0 and 25 + 6 weeks of gestational age.

Early human development
2024

Comparative Analysis of Machine Learning Algorithms Evaluating the Single Nucleotide Polymorphisms of Metabolizing Enzymes with Clinical Outcomes Following Intravenous Paracetamol in Preterm Neonates with Patent Ductus Arteriosus.

Current drug metabolism
2024

Lung ultrasound score in the decision of patent ductus arteriosus closure in neonates.

Journal of clinical ultrasound : JCU
2024

Post-ligation cardiac syndrome after surgical versus transcatheter closure of patent ductus arteriosus in low body weight premature infants: a multicenter retrospective cohort study.

European journal of pediatrics
2023

Changes in left ventricular systolic function after transcatheter patent ductus arteriosus closure in premature infants.

Annals of pediatric cardiology
2024

Role of patent ductus arteriosus in preterms in long-term outcome.

Early human development
2024

Percutaneous closure of patent ductus arteriosus versus surgical treatment in low-birth-weight preterms: a systematic review and meta-analysis.

Cardiology in the young
2023

Treatment of Patent Ductus Arteriosus in Premature Infants: Intravenous Paracetamol or Oral Ibuprofen?

Archives of Iranian medicine
2024

The impact of the route of administration on the efficacy and safety of the drug therapy for patent ductus arteriosus in premature infants: a systematic review and meta-analysis.

PeerJ
2024

Clinical and echocardiography predictors of response to first-line acetaminophen treatment in preterm infants with hemodynamically significant patent ductus arteriosus.

Journal of perinatology : official journal of the California Perinatal Association
2024

Evaluation of the association between patent ductus arteriosus approach and neurodevelopment in extremely preterm infants.

Journal of perinatology : official journal of the California Perinatal Association
2023

Personalized Evidence-Based Management of Patent Ductus Arteriosus in Preterm Infants.

Journal of cardiovascular development and disease
2024

Renal function after ductus arteriosus transcatheter closure with or without angiography in very preterm infants.

Acta paediatrica (Oslo, Norway : 1992)
2024

Secular Trends in Patent Ductus Arteriosus Management in Infants Born Preterm in the National Institute of Child Health and Human Development Neonatal Research Network.

The Journal of pediatrics
2023

The Transcatheter Closure of Patent Ductus Arteriosus in Extremely Low-Birth-Weight Infants: Technique and Results.

Journal of cardiovascular development and disease
2024

Pharmacokinetic and Pharmacodynamic Analysis of Acetaminophen and Ibuprofen Dual Therapy for Patent Ductus Arteriosus Closure in Preterm Neonates at Less Than 29 Weeks of Gestation.

Journal of clinical pharmacology
2023

Transcatheter closure in preterm infants with patent ductus arteriosus: feasibility, results, hemodynamic monitoring and future prospectives.

Italian journal of pediatrics
2023

[Risk factors and prognosis of hypotension within 72 hours after birth in extremely preterm infants].

Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics
2023

Premature closure of the arterial duct presenting with right heart failure of the fetus and ductal aneurysm postnatally.

Cardiology in the young
2023

Closing the Gap: Investigation of Various Approaches in the Management of Patent Ductus Arteriosus.

Cureus
2023

The Effects of Thyroid Hormone Levels on Patent Ductus Arteriosus Closure in Newborns.

Medeniyet medical journal
2023

Transport and Anaesthesia Consideration for Transcatheter Patent Ductus Arteriosus Closure in Premature Infants.

Journal of cardiovascular development and disease
2023

Surgical retrieval of an embolized patent ductus arteriosus closure device in an infant weighing 1050 G.

Interdisciplinary cardiovascular and thoracic surgery
2023

The effect of Daikenchuto on blood flow of the superior mesenteric artery and portal vein in ELBW: A prospective study.

Journal of neonatal-perinatal medicine
2023

Trends in Procedural Closure of the Patent Ductus Arteriosus among Infants Born at 22 to 30 Weeks' Gestation.

The Journal of pediatrics
2023

3-year follow-up of a prospective, multicenter study of the Amplatzer Piccolo™ Occluder for transcatheter patent ductus arteriosus closure in children ≥ 700 grams.

Journal of perinatology : official journal of the California Perinatal Association
2023

Association of the EPAS1 rs7557402 Polymorphism with Hemodynamically Significant Patent Ductus Arteriosus Closure Failure in Premature Newborns under Pharmacological Treatment with Ibuprofen.

Diagnostics (Basel, Switzerland)
2023

Expectant management of patent ductus arteriosus for preterm infants: A meta-analysis of randomized controlled trials.

American heart journal
2023

Experiences in Patent Ductus Arteriosus Closure of Preterm Infants Transported to Another Center for Surgical Ligation.

Turkish archives of pediatrics
2023

Patent Ductus Arteriosus in Preterm Infants and Innovative Cardiac Interventions.

NeoReviews
2023

Acetaminophen versus indomethacin for patent ductus arteriosus management in premature infants: systematic review and meta-analysis of randomized controlled trials.

Paediatrics &amp; child health
2023

Perioperative anesthetic management of premature neonates weighing less than 1500 grams undergoing transcatheter PDA (TC-PDA) closure: An institutional anesthetic experience.

Heliyon
2023

Echocardiographic parameters predicting spontaneous closure of ductus arteriosus in preterm infants.

Frontiers in pediatrics
2023

Effect of fetal lung maturation on the efficacy of acetaminophen for premature infants with patent ductus arteriosus.

Medicine
2024

Comparative Effectiveness of Surgical Ligation and Catheter Closure of Patent Ductus Arteriosus in Preterm Infants.

Pediatric cardiology
2024

Piccolo in transcatheter PDA closure multi-centre study from premature to adolescent children.

Cardiology in the young
2023

A Global Perspective on PDA Management in the Extremely Premature: Shifting Trend Toward Transcatheter Closure.

Journal of the Society for Cardiovascular Angiography &amp; Interventions
2023

Increasing the dose of ibuprofen with postnatal age to close a hemodynamically significant patent ductus arteriosus in very preterm infants.

European journal of pediatrics
2024

Patent Ductus Arteriosus Response to Treatment by Course and Associations with Perinatal and Clinical Factors.

American journal of perinatology
2023

Acetaminophen for the patent ductus arteriosus: has safety been adequately demonstrated?

Journal of perinatology : official journal of the California Perinatal Association
2023

Late aortic obstruction due to ductal vasoconstriction on pulmonic end after transcatheter patent ductus arteriosus closure in an extremely low-birth-weight infant.

Cardiology in the young
2023

Congenital heart disease: addressing the need for novel lower-risk percutaneous interventional strategies.

Expert review of cardiovascular therapy
2023

Prophylactic low-dose paracetamol for ductal closure and neurodevelopmental outcome in very preterm infants.

Acta paediatrica (Oslo, Norway : 1992)
2023

Neonatal acute kidney injury during indomethacin therapy: does it predict ductal closure?

Journal of nephrology
2023

Cost-Effectiveness Analysis of Ibuprofen Versus Indomethacin or Paracetamol for the Treatment of Patent Ductus Arteriosus in Preterm Neonates.

Current problems in cardiology
2023

An interpretable machine-learning model for predicting the efficacy of nonsteroidal anti-inflammatory drugs for closing hemodynamically significant patent ductus arteriosus in preterm infants.

Frontiers in pediatrics
2023

Interventions for patent ductus arteriosus (PDA) in preterm infants: an overview of Cochrane Systematic Reviews.

The Cochrane database of systematic reviews
2023

Outcomes of and factors associated with the development of bronchopulmonary dysplasia with pulmonary hypertension in very low birth weight infants: A retrospective study in a medical center.

Frontiers in pediatrics
2023

Trends in neonatal mortality and morbidity in very-low-birth-weight (VLBW) infants over a decade: Singapore national cohort study.

Pediatrics and neonatology
2023

Association between endotypes of prematurity and pharmacological closure of patent ductus arteriosus: A systematic review and meta-analysis.

Frontiers in pediatrics
2023

Platelets and ductus arteriosus closure in neonates.

Seminars in perinatology
2023

Combination pharmacotherapy for patent ductus arteriosus: Rationale and evidence.

Seminars in perinatology
2023

Association of patent ductus arteriosus with fetal factors and endotypes of prematurity.

Seminars in perinatology
2023

Reopening of ductus arteriosus in idiopathic premature constriction or closure of ductus arteriosus: A case series.

Journal of neonatal-perinatal medicine
2023

Hemoglobin/Red Cell Distribution width Ratio (HRR): A Novel and Promising Red Cell Parameter in Ductal Closure.

Arquivos brasileiros de cardiologia
2023

Effectiveness and safety of rectal dexibuprofen versus oral ibuprofen for closure of patent ductus arteriosus in preterm infants with gestational age<34 weeks: A pilot study.

International journal of immunopathology and pharmacology
2023

Vascular and pulmonary effects of ibuprofen on neonatal lung development.

Respiratory research
2023

Surgical ligation, not transcatheter closure, associated with a higher severity of bronchopulmonary dysplasia in extremely preterm infant intervened for patent ductus arteriosus.

Pediatric pulmonology
2022

Outcomes of preterm neonates with patent ductus arteriosus: A retrospective review from a tertiary care hospital.

JPMA. The Journal of the Pakistan Medical Association
2022

Cardiovascular changes during phototherapy in newborns.

Physiological research
2023

Predictors of a non-response to prophylactic indomethacin for patent ductus arteriosus in preterm infants.

Pediatrics and neonatology
2022

Case report: Rescue treatment with add-on selexipag in a preterm infant with suprasystemic pulmonary hypertension, pulmonary capillary hemangiomatosis, and isolated pulmonary vein stenosis.

Frontiers in cardiovascular medicine
2022

Paracetamol (acetaminophen) for patent ductus arteriosus in preterm or low birth weight infants.

The Cochrane database of systematic reviews
2022

Outcomes of Surgical Management for Patent Ductus Arteriosus in Infants in Nigeria.

Texas Heart Institute journal
2023

Oral Ibuprofen Is More Effective than Intravenous Ibuprofen for Closure of a Patent Ductus Arteriosus: Can Pharmacokinetic Modeling Help Us to Understand Why?

Neonatology
2023

Outpatient prescription of pulmonary vasodilator therapy to preterm children with bronchopulmonary dysplasia.

Acta paediatrica (Oslo, Norway : 1992)
2022

Bruck Syndrome: Beyond the Obvious.

Fetal diagnosis and therapy
2023

Left ventricular function before and after percutaneous patent ductus arteriosus closure in preterm infants.

Pediatric research

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Fechamento prematuro do canal arterial.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Fechamento prematuro do canal arterial

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Ainda não achamos doenças com sintomas parecidos o suficiente.

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Enteral feeding during cyclooxygenase inhibitor treatment for patent ductus arteriosus: A systematic review.
    Pediatrics international : official journal of the Japan Pediatric Society· 2026· PMID 41665023mais citado
  2. Patent ductus arteriosus: emerging trial evidence firmly supports conservative management in preterm infants.
    Current opinion in pediatrics· 2026· PMID 41568452mais citado
  3. Premature foramen ovale restriction/closure in pregnancy: echocardiographic features and overlap with aortic coarctation.
    The journal of maternal-fetal &amp; neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians· 2026· PMID 41802915mais citado
  4. Fetal Intervention for Giant Chorangioma with Prenatal Ductus Arteriosus Closure: A Case Report.
    Fetal diagnosis and therapy· 2026· PMID 41785200mais citado
  5. Favorable Procedural Outcomes in Lower Versus Higher Weight Premature Infants Undergoing Transcatheter Patent Ductus Arteriosus Closure.
    Journal of the Society for Cardiovascular Angiography &amp; Interventions· 2026· PMID 41726054mais citado
  6. Paracetamol Concentrations and Time-Course of Ductus Arteriosus Diameter in Extremely Preterm Neonates: A Population Pharmacokinetic-Pharmacodynamic Analysis.
    Clin Pharmacokinet· 2025· PMID 40889095recente
  7. The Timing and Factor of Ductus Arteriosus Closure in Infants with Down Syndrome Born at Term and Late-Preterm.
    Pediatr Cardiol· 2026· PMID 40258985recente
  8. Systemic Inflammatory Indices as New Biomarkers for Hemodynamically Significant Ductus Arteriosus.
    Arq Bras Cardiol· 2024· PMID 39630813recente
  9. Premature Closure of the Ductus Arteriosus and Veno-Arterial Extracorporeal Membrane Oxygenation in Critically Ill Neonates: A 10-Year Single-Center Retrospective Study.
    Pediatr Cardiol· 2025· PMID 39073480recente
  10. Echocardiographic findings and pregnancy outcomes for fetuses with complete closure of the ductus arteriosus.
    J Clin Ultrasound· 2024· PMID 38662985recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:95486(Orphanet)
  2. MONDO:0019823(MONDO)
  3. GARD:19271(GARD (NIH))
  4. Busca completa no PubMed(PubMed)
  5. Q55788898(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Fechamento prematuro do canal arterial
Compêndio · Raras BR

Fechamento prematuro do canal arterial

ORPHA:95486 · MONDO:0019823
🇧🇷 Brasil SUS
Triagem
qPCR para deleção de SMN1 em sangue seco
PNTN
Fase 5
Incidência BR
1:10.000
Geral
CID-10
Q25.8 · Outras malformações congênitas das grandes artérias
CID-11
MedGen
UMLS
C3532264
EuropePMC
Wikidata
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades